3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
16
Triple Negative Breast Neoplasms
1
Rectal Neoplasms
1
Malignant Solid Neoplasm
1
Inflammatory Breast Neoplasms
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms, Male
1
Bladder Urothelial Carcinoma
1
Advanced Breast Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
Rituximab
173
Cyclophosphamide
157
Vincristine
72
fludarabine phosphate
71
Doxorubicin
69
Etoposide
68
Prednisone
67
Filgrastim
58
Methotrexate
52
Cytarabine
51
fludarabine
49
Melphalan
48
Busulfan
47
Tacrolimus
41
Whole-Body Irradiation
39
Mycophenolic Acid
39
Granulocyte Colony-Stimulating Factor
37
Antilymphocyte Serum
31
Peripheral Blood Stem Cell Transplantation
30
Radiotherapy
27
Lenalidomide
25
Dexamethasone
25
Carmustine
23
Stem Cell Transplantation
22
Cyclosporine
22
Bortezomib
22
Gemcitabine
20
Bendamustine Hydrochloride
20
ibritumomab tiuxetan
19
Alemtuzumab
19
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma
×
PF-05280014
×
Clear all
No trials found.